comparemela.com
Home
Live Updates
Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth : comparemela.com
Boan Biotech Announces 2022 Financial Results, Showing Accelerated Innovation and Strong 225% Revenue Growth
YANTAI, CHINA - Media OutReach - 28 March 2023 - Boan Biotech (6955.HK) announced its 2022 financial results and recent business developments on March 27, 2023. 2022 business...
Related Keywords
Yantai
,
Shandong
,
China
,
Singapore
,
Shenzhen
,
Guangdong
,
Hong Kong
,
Shanghai
,
Jiang Hua
,
Hunan
,
Chinese
,
Sino Biopharm
,
Phage Display Technology Platform
,
Astrazeneca
,
National Reimbursement Drug List
,
Bispecific Engager Technology Platform
,
Technology Platform
,
Boan Biotech
,
Biological License Application
,
Main Board
,
Hong Kong Stock Exchange
,
Shanghai Hong Kong Stock Connect
,
Shenzhen Hong Kong Stock Connect
,
Reimbursement Drug List
,
Human Antibody Transgenic Mouse
,
Phage Display Platform
,
Bispecifict Cell Engager Platform
,
Antibody Drug Conjugate
,
Chief Executive Officer
,
Bispecifict Cell Engager Technology Platform
,
Taboan
,
Biotech
,
Announces
,
2022
,
Financial
,
Results
,
,
Showing
,
Aaccelerated
,
Innovation
,
Hand
,
Strong
,
225
,
Revenue
,
Growth
,
comparemela.com © 2020. All Rights Reserved.